ETEhab Tharwat

Ehab Tharwat

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ehab Tharwat has a total of 81 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Prospective validation of transcutaneous levator recession for non-thyroid lid retraction: efficacy, safety, and predictable outcomes

    by Ezzat Nabil Abbas Ibrahim, Mohammed Eid Abd El-Salam, Omar Hassan Salama Selim, Mohamed Gaber Okasha Abdelazim, Sarah Abbas Alshamarti, Saif Abbas Alshamarti, Mahmoud Fawzy Zaky Morsy, Essam Mahmoud Abd Ellateef, Ehab Tharwat, Fathy Mohamed Abo Elftouh Elsalhy

    To prospectively evaluate the efficacy and safety of transcutaneous levator aponeurosis recession for upper eyelid retraction resulting from non-thyroid etiologies and to establish surgical dose-response relationships. This prospective interventional case series included 29 eyes of 27 patients with upper eyelid retraction secondary to non-thyroid causes. All patients underwent transcutaneous levator aponeurosis recession by a single surgeon. Preoperative and postoperative margin reflex distance (MRD1) were assessed by two independent masked observers. Primary outcome was change in MRD1. Secondary outcomes included dose-response relationship, complications, and subgroup analysis by etiology and severity. Mean follow-up was 22.4 ± 8.3 months. Mean preoperative MRD1 improved from 6.5 ± 0.8 mm to 3.9 ± 0.4 mm (p < 0.001). Mean recession amount was 12.4 ± 2.3 mm. Average recession required per 1 mm MRD1 reduction was 5.3 mm overall. Etiological analysis showed comparable dose-response in myogenic (5.2 mm) and neurogenic (5.1 mm) cases, while mechanical etiologies required greater recession (7.3 mm). Severe cases demonstrated more efficient correction (4.3 mm per 1 mm) compared to moderate cases (5.6 mm). Under-correction occurred in 2 eyes (6.9%), overcorrection in 4 eyes (13.8%). No major complications occurred. Levator aponeurosis recession is effective and safe for non-thyroid upper eyelid retraction. The surgical dose-response appears to vary by etiology and severity, with mechanical cases tending to require more aggressive recession and severe cases showing greater efficiency. These findings provide preliminary guidance to support individualized surgical planning, while larger studies are needed to confirm and refine these trends.

  • Open Access

    Sponge Application of Mitomycin C vs Sub-Tenon Injection in Trabeculectomy: A Randomized Controlled Trial

    by Sayed Mostafa Elsayed Abdelhafeez, Hazem Elbadry Mohammed Mohammed, Ehab Tharwat, Mohamed Mohamed-Aly Ibrahim, Ahmed Mohamed Raafat Tawfik, Ramadan Mohamed Abdelrahman Elgohary, Mohammed Saad Ibrahim Alabshihy, Ahmed Mohammed Sakr, Anas M Ebrahim, Ahmed Rabie Mohammed, et al.

    Glaucoma represents a major driver of irreversible blindness globally, with intraocular pressure (IOP) reduction serving as the primary therapeutic objective. Trabeculectomy (TE), often augmented with mitomycin C (MMC), is considered the gold standard surgical treatment; however, its success is frequently compromised by postoperative fibrosis. Various MMC delivery techniques—such as sponge application and sub-Tenon injection (STI)—differ in their drug distribution profiles and may consequently affect surgical outcomes. Accordingly, we aimed to evaluate and compare the efficacy and safety of TE performed with sponge-applied MMC against STI-MMC. This prospective, randomized, controlled clinical trial enrolled 50 patients having primary or secondary glaucoma who were randomly allocated to undergo TE with either MMC sponge application (group A, n = 25) or STI-MMC (group B, n = 25) and followed for 12 months. The primary outcome measures included IOP reduction, while secondary outcomes assessed bleb morphology using the Indiana Bleb Appearance Grading Scale (IBAGS), bleb integrity via Seidel testing, and the requirement for postoperative glaucoma medications. Both groups achieved significant IOP reductions without intergroup differences at all postoperative intervals (p > 0.05). Bleb morphology differed significantly, with higher localized blebs in group A and flatter and more diffuse blebs in group B (p < 0.001). There were no significant differences in bleb vascularity or integrity. Postoperative medication needs were comparable (p = 0.732). Both STI-MMC and sponge-applied MMC are equally effective for IOP control, though STI may produce more diffuse blebs, potentially reducing long-term complications. Further long-term studies are warranted. This study demonstrates STI-MMC noninferiority compared to sponge-applied MMC in achieving sustained IOP reduction after TE while highlighting distinct bleb morphologies with potential safety implications. These findings advocate for individualized MMC selection based on patient-specific risk factors, balancing technical simplicity with potential long-term safety. Retrospectively registered at ClinicalTrials.gov (Identifier: NCT06925412). Abdelhafeez SM, Mohammed Mohammed HE, Tharwat E, et al. Sponge Application of Mitomycin C vs Sub-Tenon Injection in Trabeculectomy: A Randomized Controlled Trial. J Curr Glaucoma Pract 2025;19(4):199–207.

  • Efficacy of implantable Collamer lens after corneal cross-linking in patients with keratoconus: a systematic review and meta-analysis

    by Akram Fekry Elgazzar, Ehab Tharwat, Sherein Diab, Walid Shaban Abdella, Ahmed Abdelaziz, Sewar Elejla, Mariam Mohamed Ahmed, Mohamed Abdelmonem Kamel, Esraa Qobeia, Ahmed Nabil Selim, et al.

    Purpose To determine the efficacy of implantable Collamer lens (ICL) implantation after corneal collagen cross-linking in keratoconus. Methods We searched PubMed, Cochrane CENTRAL, SCOPUS, Web of Science, and Google Scholar from inception until October 2022. We included the relevant studies that assessed ICL implantation post-corneal collagen cross-linking in patients with keratoconus. The efficacy endpoints were corrected distance visual acuity (CDVA), uncorrected distance visual acuity (UDVA), manifest refraction (sphere, cylinder, spherical equivalent), and keratometry. Results Seven observational studies were eligible for this systematic review and meta-analysis. ICL implantation showed an improvement in UDVA, 6 months postoperative, with a mean change of − 1.27 log MAR (95% CI [− 1.63 to − 0.9]. However, there was a non-significant improvement in CDVA with a mean change of − 0.04 log MAR (95% CI [− 0.11 to 0.02]. A trend toward the improved sphere and spherical equivalent was observed for all eyes after the ICL implantation approach: mean change of 6.82 diopters (95% CI 3.24 to 10.4) for the sphere and 7.30 diopters (95% CI [4.18 to 10.43]) for the spherical equivalent. The refractive cylinder was not improved after ICL implantation 0.62 diopters (95% CI [− 0.53 to 1.77]. Conclusion The ICL implantation approach appears to be effective for improving visual acuity in patients with keratoconus without adversely affecting corneal keratometry after crosslinking.


  • Open Access

    Aflibercept or ranibizumab for diabetic macular edema

    by Mahmoud Abdelhalim Ali Ali, Hanan Saied Hegazy, Mohammed Othman Abdelkhalek Elsayed, Ehab Tharwat, Mona Nabeh Mansour, Mohamed Hassanein, Ezzeldin Ramadan Ezzeldin, Ashraf Mohammed GadElkareem, Essam Mahmoud Abd Ellateef, Ahmed A. Elsayed, et al.

    Background: Vascular endothelial growth factor (VEGF) is the primary substance involved in retinal barrier breach. VEGF overexpression may cause diabetic macular edema (DME). Laser photocoagulation of the macula is the standard treatment for DME; however, recently, intravitreal anti-VEGF injections have surpassed laser treatment. Our aim was to evaluate the efficacy of intravitreal injections of aflibercept or ranibizumab for managing treatment-naive DME. Methods: This single-center, retrospective, interventional, comparative study included eyes with visual impairment due to treatment-naive DME that underwent intravitreal injection of either aflibercept 2 mg/0.05 mL or ranibizumab 0.5 mg/0.05 mL at Al-Azhar University Hospitals, Egypt between March 2023 and January 2024. Demographic data and full ophthalmological examination results at baseline and 1, 3, and 6 months post-injection were collected, including the best-corrected distance visual acuity (BCDVA) in logarithm of the minimum angle of resolution (logMAR) notation, slit-lamp biomicroscopy, dilated fundoscopy, and central subfield thickness (CST) measured using spectral-domain optical coherence tomography. Results: Overall, the 96 eyes of 96 patients with a median (interquartile range [IQR]) age of 57 (10) (range: 20–74) years and a male-to-female ratio of 1:2.7 were allocated to one of two groups with comparable age, sex, diabetes mellitus duration, and presence of other comorbidities (all P >0.05). There was no statistically significant difference in baseline diabetic retinopathy status or DME type between groups (both P >0.05). In both groups, the median (IQR) BCDVA significantly improved from 0.7 (0.8) logMAR at baseline to 0.4 (0.1) logMAR at 6 months post-injection (both P = 0.001), with no statistically significant difference between groups at all follow-up visits (all P >0.05). The median (IQR) CST significantly decreased in the aflibercept group from 347 (166) µm at baseline to 180 (233) µm at 6 months post-injection, and it decreased in the ranibizumab group from 360 (180) µm at baseline to 190 (224) µm at 6 months post-injection (both P = 0.001), with no statistically significant differences between groups at all follow-up visits (all P >0.05). No serious adverse effects were documented in either group. Conclusions: Ranibizumab and aflibercept were equally effective in achieving the desired anatomical and functional results in patients with treatment-naive DME in short-term follow-up without significant differences in injection counts between both drugs. Larger prospective, randomized, double-blinded trials with longer follow-up periods are needed to confirm our preliminary results.


  • Open Access

    Non-penetrating deep sclerectomy versus combined trabeculotomy–trabeculectomy in primary congenital glaucoma

    by Ibrahim Hassan Elabd, Ahmed A Elsayed, Akram Fekry Elgazzar, Ezzeldin Ramadan Ezzeldin, Mohamed Hassanein, Haitham Beshr Soliman, Ashraf Mohammed GadElkareem, Basheer Eltantawy, Mohamed Yahia Omran, Mohamed Gaber Okasha, et al.

    Background: The primary mode of therapy in children with primary congenital glaucoma (PCG) and mild or no corneal edema is goniotomy, which has a high success rate. However, in developing countries, the diagnosis of PCG is usually delayed, and corneal cloudiness interferes with goniotomy. Therefore, trabeculotomy may be the best choice in such eyes. We compared the short-term efficacy and safety of primary combined trabeculotomy–trabeculectomy (primary CTT) with that of non-penetrating deep sclerectomy (NPDS) in managing PCG. Methods: This prospective, randomized, comparative study included patients with PCG referred to Al-Azhar University Hospitals within a 1-year period. Eyes were randomly allocated to one of two groups: eyes in NPDS group underwent NPDS, and those in primary CTT group underwent primary CTT. Baseline and frequent postoperative assessments of intraocular pressure (IOP), cup-to-disc ratio (C/D ratio), corneal diameter, and axial length were performed for up to 6 months. The success rates were recorded in both groups. Results: Forty eyes of 26 patients were included, with 20 eyes allocated to each group. The mean (standard deviation) age of all patients was 12.9 (9.5) months, with comparable ages and sex ratios between groups (both P > 0.05). Both groups demonstrated a significant reduction in IOP and C/D ratio at each postoperative visit compared to the baseline visit (all P < 0.001), with no significant difference detected between the groups (all P > 0.05), except for a significantly lower IOP in NPDS group at 1 month (P < 0.05). The corneal diameter and axial length were comparable between groups at baseline and remained unchanged at all postoperative visits (all P > 0.05). The groups had comparable success rates (P > 0.05). No serious complications were detected. Conclusions: CTT and NPDS both yielded reasonable IOP control and reversal of cupping in eyes with PCG. We observed equal effectiveness of the surgical procedures without major safety concerns. Further large-scale clinical trials with longer follow-up periods are needed to verify our preliminary findings.


  • Open Access

    Effect of cycloplegia on the refractive status of children

    by Ehab Tharwat, Mohamed Hassanein, Ezzeldin R. Ezzeldin, Haitham B. Soliman, Basheer Eltantawy, Akram F. Elgazzar, Walid S. Abdella, Amr M.E. Abdelkader

    Background: The American Optometric Association (AOA), in its 2017 Recommendation for Clinical Practice, proposed cycloplegic testing when initially screening preschool children to detect potential vision-impairing diseases such as strabismus, amblyopia and anisometropia. Aim: This study aims to detect the effect of cycloplegia on the measurement of refractive errors in children. Setting: Ophthalmology department, Al-Azhar University, Egypt. Methods: This retrospective interventional study included 388 children with refractive error attending our outpatient clinic in the ophthalmology department, at Al-Azhar University between January 2020 and April 2022. Cycloplegia was induced in each child with topical eye drops of 1% cyclopentolate instilled two times at 5-min intervals. The same optometrist repeated an auto-refraction 30 min after the last eye drop was applied. Results: We compared the pre- and post-cycloplegic refractions and found that the sphere, spherical equivalence and cylinder had significant hypermetropic shift after cycloplegia (P = 0.001). Conclusion: Cycloplegic refractions are more accurate and eliminate the risk of inaccurate refractive error findings, which is essential when managing children. Contribution: This article provides valuable insight, which may inform public health policy.


  • Open Access

    Suprachoroidal triamcinolone versus posterior subtenon triamcinolone either alone or formulated in the management of diabetic macular edema

    by Ehab Tharwat, Riad Elzaher Hassan Ahmed, Basheer Eltantawy, Ezzeldin Ramadan Ezzeldin, Akram Fekry Elgazzar

    Purpose: This study aims to compare posterior subtenon triamcinolone acetonide injection either formulated or alone versus suprachoroidal triamcinolone in the management of diabetic macular edema. Methods: This study is a prospective interventional study that included 75 patients, divided into three groups, each group with 25 patients. Group I received a combination of triamcinolone acetonide (TA) (40 mg) and VISCOAT, which is a combination of sodium chondroitin sulfate (20 mg) and sodium hyaluronate (15 mg). The injection was done in the posterior subtenon space using the NAGATA cannula. Group II received TA (40 mg) in the posterior subtenon space. Group III underwent an injection of 4 mg/100µl of TA in the supra choroidal space. Results: We found a statistically significant difference between the three studied groups regarding BCVA (P = 0.001) and CMT at six months postoperative (P = 0.001) with the highest median BCVA and lowest median CMT observed in the formulated TA group. Conclusion: We concluded that early treatment of DME by formulated TA is better than TA alone, and suprachoroidal TA in the form of increasing the BCVA and decreasing the CMT without any elevation of IOP. Trial registration number NCT05464953. Date of registration 17/7/2022 (retrospectively registered).


  • Open Access

    Modified Anterior Lamellar Recession for All Grades of Upper Eyelid Trachomatous Cicatricial Entropion

    by Ezzat Nabil Abbas Ibrahim, Ehab Tharwat, Mahmoud Mohammed Ahmed Ali Khalil, Ahmed Rabie Mohammed, Mostafa F Mohammed, Ahmed Mohammed Madinah Alkady, Ezzeldin Ramadan Ezzeldin, Riad Elzaher Hassan Ahmed, Yasser H Al-Faky, Mohamed Hassanein, et al.

    Purpose: This study aims to assess the combination of anterior lamellar recession (ALR) with blepharoplasty, suprasternal fixation, and internal eyelash bulb extirpation of aberrant lashes posteriorly located in patients with any grade of upper eyelid trachomatous cicatricial entropion. Patients and Methods: We reviewed the clinical data of eighty-six patients (143 eyelids) including age, gender, systemic medical illnesses, and comprehensive ophthalmological assessment. Eyelid evaluation was recorded, including laterality, previous surgical technique used, possible trichiasis etiology, abnormality of the lid margin, tarsal plate consistency (shrinkage or loosening), skin fold overhanging, laxity of the pretarsal skin, margin reflex distance 1 (MRD1), lagophthalmos, and lid retraction. The success rate was assessed at 3, 6, 9, and 12 months postoperative. Results: The success rate was 97.2% in the third month, which decreased significantly to 92.3% in the 6th month and 90.2% in the 9th month (P = 0.01, and 0.001 respectively). In the 9th month, we had fourteen failed cases. All of them were submitted for a second intervention. Three underwent electrolysis, four cases underwent re-internal bulb extirpation, four cases underwent the same procedure, and three cases underwent epilation. The success of the failed cases after the second intervention was significantly associated with the type of reintervention (P = 0.03), in which all of them succeed except two cases that underwent epilation. Kaplan-Meier analysis showed that the mean recurrence time in our study was 6.8 months (95% CI = 5.8– 7.7 months). Conclusion: This study showed the combination of ALR with blepharoplasty, suprasternal fixation, and cauterization or internal bulb extirpation of posteriorly located lashes procedure resulted in a high success rate in patients with any form of UCE with no increase in incidence or degree of lagophthalmos associated with UCE.


  • Open Access

    Anterior lamellar recession versus bilamellar tarsal rotation in upper lid cicatricial trichiasis

    by Ezzeldin Ramadan Ezzeldin, Akram Fekry Elgazzar, Mostafa Osman Hussein, Ezzat Nabil Abbas Ibrahim, Ehab Tharwat

    PURPOSE: In recent years, there has been a significant shift from this destructive procedure to a reconstructive procedure such as anterior lamellar recession (ALR) and bilamellar tarsal rotation (BLTR). The aim is to report the outcomes and success rates of ALR compared to BLTR in patients with upper lid cicatricial trichiasis. MATERIALS AND METHODS: Our study is a prospective, interventional, comparative study that was conducted at the Ophthalmology Department of Al-Azhar University Hospital, New Damietta, Egypt. Our study was conducted on 62 eyes of 45 consecutive patients suffering from upper lid cicatricial trichiasis that required surgical intervention (17 patients were bilateral and 28 were unilateral). Thirty-three of them were treated by ALR (group 1), and 29 of them by BLTR (group 2). All statistical analysis was performed using the SPSS version 26. RESULTS: As regards the immediate postoperative correction, we found that adequate correction was significantly higher in the ALR group at all follow-up periods (P < 0.05). However, the overcorrection and undercorrection were significantly higher in the BLTR group (P < 0.05). Compared to the ALR group, the BLTR group saw a greater undercorrection at 1, 3, and 6 months (9.3%% vs. 0%; P = 0.048, 18.6% vs. 1.8%%; P = 0.009, 18.6%% vs. 1.8%; P = 0.009, 18.6%% vs. 1.8%; P = 0.009, respectively). CONCLUSION: ALR is better than BLTR in the treatment of upper lid cicatricial trichiasis.


  • Open Access

    Comparative study between three-snip punctoplasty with and without mitomycin C in the management of punctal stenosis or occlusion

    by Ehab Tharwat, Mostafa O. Hussein

    Background: Punctal stenosis is a progressive constriction of the puncta with resultant epiphora. One of the most effective treatment options is one- to four-snip punctoplasty with or without mitomycin C (MMC). Aim: The aim of this study was to assess the effectiveness of intraoperative MMC in increasing the success rate of three-snip punctoplasty in cases of punctal stenosis. Patients and methods: This is a nonrandomized interventional prospective comparative study that was conducted at the Department of Ophthalmology, Al-Hussein and Bab El Sheria Al-Azhar University Hospitals, Cairo, Egypt. It included 31 eyes of 18 patients who underwent three-snip punctoplasty. The patients were divided into two groups: group 1 (15 eyes), in which MMC was not used during surgery, and group 2 (16 eyes), in which MMC was used intraoperatively for 2 min. Complete ocular examinations were performed in all patients using the slit lamp. Punctal stenosis grading was done as follows: grade 0 (absent punctum), grade 1 (a membrane covering the papilla), grade 2 (less than average size, however, can be recognized), grade 3 (normal), grade 4 (small slit P=0.000). Conclusion: MMC demonstrated a favorable, secure, and efficient adjunct treatment for punctal stenosis in the punctoplasty procedure.